Assessment of Phosphate and Osmolarity Levels in Chronically Administered Eye Drops

Journal Title: TÜRK OFTALMOLOJİ DERGİSİ - Year 2019, Vol 49, Issue 3

Abstract

Objectives: To assess phosphate and osmolarity levels of chronically administered eye drops commercially available in Turkey. Materials and Methods: A total of 53 topical eye drops including 18 antiglaucoma drugs, 4 nonsteroidal anti-inflammatory drugs (NSAIDs), 10 corticosteroids, 7 antihistaminics, and 14 artificial tears identified using the Vademecum Modern Medications Guideline (2018) were included in the study. Phosphate levels were assessed using Roche Cobas C501 analyzer (Roche Diagnostics GmbH, Mannheim, Germany) and the respective kits. Osmolarity was assessed using Vescor Vapro 5600 vapor pressure osmometer (Sanova Medical Systems, Vienna, Austria). Mean phosphate and osmolarity levels were obtained after averaging three measurements. Eye drops were categorized as isoosmolar, hypoosmolar and hyperosmolar based on physiologic tear osmolarity range (296.5±9.8 mOsm/L). Results: The highest phosphate concentration was found in the antiglaucoma group (20.3±35.4 mmol/L), followed by antihistaminics (17.3±17.9 mmol/L), corticosteroids (15.2±19.1 mmol/L), artificial tears (0.8±1.0), and NSAIDs (0.04±0.08). Percentage of medications in the hyperosmolar category was highest in the NSAI group (75%), followed by antihistaminics (43%), corticosteroids (20%), and antiglaucoma drugs (19%). Nearly all of the artificial tear formulations were in the hypoosmolar (71%) or isoosmolar (21%) categories. Conclusion: Approximately 40% of glaucoma medications and approximately 60% of corticosteroid and antihistaminic medications had a phosphate concentration higher than the physiologic tear phosphate level (1.45 mmol/L).

Authors and Affiliations

Onur Özalp, Eray Atalay, İbrahim Özkan Alataş, Zeynep Küskü Kiraz, Nilgün Yıldırım

Keywords

Related Articles

Assessment of Phosphate and Osmolarity Levels in Chronically Administered Eye Drops

Objectives: To assess phosphate and osmolarity levels of chronically administered eye drops commercially available in Turkey. Materials and Methods: A total of 53 topical eye drops including 18 antiglaucoma drugs, 4 nons...

Clinical Features and Surgical Results in Harada-Ito Surgery Patients

Symptomatic excyclotorsion is an important clinical problem, especially in acquired superior oblique muscle palsy. Excyclotorsion can disrupt the fusion and cause torsional diplopia. Harada-Ito surgery (HI) is a widely u...

Retina and Optic Disc Characteristics in Amblyopic and Non-amblyopic Eyes of Patients with Myopic or Hyperopic Anisometropia

Objectives: To compare retinal and optic disc characteristics between amblyopic and non-amblyopic eyes in patients with myopic and hyperopic anisometropia measured with optical coherence tomography (OCT). Materials and M...

Retinal Prostheses and Artificial Vision

In outer retinal degenerative diseases such as retinitis pigmentosa, choroideremia, and geographic atrophy, 30% of the ganglion cell layer in the macula remains intact. With subretinal and epiretinal prostheses, these in...

Skizis Benzeri Makülopati ile İlişkili Glokomatöz Optik Sinir Başı Defektlerinin Üç Boyutlu Optik Koherens Tomografi Özellikleri ve Tedavisi

İleri glokomlu bir olgudaki optik sinir (OS) başı yapısal defektleri ile ilişkili maküler retinoskizisin üç boyutlu (3B) spektral domain optik koherens tomografi (SD-OKT) bulgularını ve tedavi sonuçlarını sunmaktayız. Of...

Download PDF file
  • EP ID EP592636
  • DOI 10.4274/tjo.galenos.2018.43827
  • Views 95
  • Downloads 0

How To Cite

Onur Özalp, Eray Atalay, İbrahim Özkan Alataş, Zeynep Küskü Kiraz, Nilgün Yıldırım (2019). Assessment of Phosphate and Osmolarity Levels in Chronically Administered Eye Drops. TÜRK OFTALMOLOJİ DERGİSİ, 49(3), 123-129. https://europub.co.uk/articles/-A-592636